Chemical Structure : DDO3602
货号: PC-25824Not For Human Use, Lab Use Only.
DDO3602 is a potent, effective small molecule HSP90-mediated proteolysis-targeting chimera (HSPTAC) degrader of PARP1 with DC50 of 490.3 nM in MCF-7 cells, induces PARP1 degradation through a multi-E3 ubiquitin ligase-mediated degradation pathway.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
DDO3602 is a potent, effective small molecule HSP90-mediated proteolysis-targeting chimera (HSPTAC) degrader of PARP1 with DC50 of 490.3 nM in MCF-7 cells, induces PARP1 degradation through a multi-E3 ubiquitin ligase-mediated degradation pathway.
DDO3602 effectively degrades PARP1 levels by 69.7% at a concentration of 1 μM.
DDO3602 exhibits significant MCF-7 antiproliferative activity (IC50 = 187 nM) for MCF-7 cells.
DDO3602 recruits multiple E3 ubiquitin ligases, including such as tripartite motif-containing protein 25 (TRIM25), ubiquitin protein ligase 5 (UBR5), Myc-binding protein 2 (MYCBP2), membrane-associated RING finger protein 5 (MARCHF5), and tripartite motif-containing protein 50 (TRIM50), thereby promoting PARP1 degradation via a UPS-dependent manner.
DDO3602 effectively induces G2/M cell cycle arrest and DNA damage.
DDO3602 inhibits the migration of MCF-7 cells and exhibits effective anticancer activity in the MCF-7 xenograft tumor mouse model.
| 分子量 | 900.07 | |
| 分子式 | C51H58FN7O7 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Wei Liu, et al. J Med Chem. 2025 Oct 9;68(19):19933-19954.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright